In this episode, we interview Michelle Carnahan, President of Thirty Madison. We discuss Michelle’s pivot from pharmaceutical executive to leader of a health tech unicorn and what that means for Thirty Madison going forward.

Thirty Madison’s mission is to be a human-first healthcare company delivering specialized care and treatment to everyone. They recently completed a $140M Series C raise led by HealthQuest Capital. They join Maveron and Polaris Partners as lead investors in Thirty Madison.